When you're looking at a new investment for the first time, the best place to start is the company's last quarterly report. Take, for example, health-care stalwart and reliable dividend stock Johnson & Johnson (NYSE: JNJ). The company reported strong results and raised its guidance for the year; but what were the major growth drivers, and how does its valuation stack up against competitors like Abbott Labs (NYSE: ABT)? In the following video, a segment from The Motley Fool's health-care show Market Checkup, analysts David Williamson and Max Macaluso examine the highs and lows of the company's second quarter.
One of the best parts of owning big pharma stocks like Johnson & Johnson is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report, "Secure Your Future With 9 Rock-Solid Dividend Stocks," outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.